Your browser doesn't support javascript.
loading
Quality of Life in Patients With Hypoparathyroidism After Treatment for Thyroid Cancer.
Büttner, Matthias; Locati, Laura D; Pinto, Monica; Araújo, Cláudia; Tomaszewska, Iwona M; Kiyota, Naomi; Vidhubala, E; Brannan, Christine; Hammerlid, Eva; Husson, Olga; Salem, Dina; Ioannidis, Georgios; Gamper, Eva; Arraras, Juan Ignacio; Andry, Guy; Inhestern, Johanna; Theurer, Juliane; Taylor, Katherine; Singer, Susanne.
Afiliação
  • Büttner M; Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center Mainz, Mainz, Germany.
  • Locati LD; University Cancer Centre, Mainz, Germany.
  • Pinto M; Head & Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Araújo C; Rehabilitation Medicine Unit, Strategic Health Services Department, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Naples, Italy.
  • Tomaszewska IM; Service of Surgical Oncology, Instituto Português do Oncologia do Porto Francisco Gentil, Porto, Portugal.
  • Kiyota N; Department of Medical Education, Jagiellonian University Medical College, Krakow, Poland.
  • Vidhubala E; Department of Medical Oncology and Hematology, Cancer Center, Kobe University Hospital, Kobe, Japan.
  • Brannan C; Nellai Cancer Care Center, Tirunelveli, Tamil Nadu, India.
  • Hammerlid E; Mount Vernon Cancer Centre, East & North Herts NHS Trust, Northwood, London, UK.
  • Husson O; Department of Otorhinolaryngology-Head and Neck Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Salem D; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands.
  • Ioannidis G; Clinical Oncology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
  • Gamper E; Oncology Department, Nicosia General Hospital, Nicosia, Cyprus.
  • Arraras JI; Department of Nuclear Medicine, Department of Psychiatry, Psychotherapy, and Psychosomatic Medicine, Psychiatry II Medical University of Innsbruck, Innsbruck, Austria.
  • Andry G; Oncology Departments, Complejo Hospitalario de Navarra, Pamplona, Spain.
  • Inhestern J; Surgery Department, Jules Bordet Institute, Brussels, Belgium.
  • Theurer J; Clinic of Otorhinolaryngology, Oberhavel Kliniken, Hennigsdorf, Germany.
  • Taylor K; Department of Surgery, University Medical Center Mainz, Mainz, Germany.
  • Singer S; Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center Mainz, Mainz, Germany.
J Clin Endocrinol Metab ; 105(12)2020 12 01.
Article em En | MEDLINE | ID: mdl-32918085
ABSTRACT

PURPOSE:

Surgical complications such as hypoparathyroidism (HPT) or vocal cord palsy are seldom assessed when the quality of life (QOL) in thyroid cancer patients is investigated. The aim of this study was to measure the QOL difference in thyroid cancer survivors with and without HPT.

METHODS:

Participants for this analysis were enrolled in 13 countries from a study that pilot-tested a thyroid cancer-specific QOL instrument. They were included if they had been diagnosed with thyroid cancer at least 9 months previously. QOL was measured using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core (EORTC QLQ-C30) and some items on HPT symptoms (eg, tingling in fingers or toes). HPT status and other clinical data were extracted from the patients' medical charts. Comparisons of QOL domains between patients with and without HPT were performed using Mann-Whitney U test. The occurrence of HPT-related symptoms was compared using chi-square tests. Multiple ordinal regression analysis was performed to evaluate factors that might affect QOL.

RESULTS:

Eighty-nine patients participated in this study, 17 of whom were considered to have HPT. Patients in the HPT group reported significantly reduced QOL in 9 of the 15 scales of the EORTC QLQ-C30 compared to patients without HPT. Regression analysis showed that HPT was independently negatively associated with various scales of the QLQ-C30. Both groups showed a high prevalence of typical HPT symptoms.

CONCLUSION:

Thyroid cancer patients with HPT report significantly impaired QOL compared to thyroid cancer survivors without HPT. The assessment of HPT should be considered when measuring QOL in thyroid cancer patients.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complicações Pós-Operatórias / Qualidade de Vida / Neoplasias da Glândula Tireoide / Sobreviventes de Câncer / Hipoparatireoidismo Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complicações Pós-Operatórias / Qualidade de Vida / Neoplasias da Glândula Tireoide / Sobreviventes de Câncer / Hipoparatireoidismo Idioma: En Ano de publicação: 2020 Tipo de documento: Article